I want to personally welcome you to the Thoracic Oncology Program website. Our goal is to provide compassionate, state-of-the-art multidisciplinary care to patients diagnosed with lung cancer, mesothelioma and other thoracic malignancies.
A diagnosis of lung cancer is especially difficult. Patients must deal not only with disease itself, but with the stigma associated with the diagnosis. Even patients who have quit smoking or never smoked at all shoulder these burdens. I reject these attitudes, which are totally unjust. At UCSF, our sole focus is on treatment and hope, not on blaming the victim.
We are proud to be a regional, national, and international referral center for lung cancer. Our surgeons are known for their willingness to be aggressive in the appropriate case. We are also a high volume center for thoracic surgery, the largest on the West Coast. Our post-operative mortality rates are among the lowest anywhere.
We have extensive experience in performing minimally invasive thoracic surgery. That means shorter hospital stays, less post-operative pain, and a more rapid return to normal activities. For patients who need chemotherapy after surgery, it means they can begin their treatment faster and are better able to tolerate higher doses.
Our medical oncology group is led by two outstanding physicians, Thierry Jahan and Sarita Dubey. Other specialists treating patients, from radiation oncology, pulmonology, pathology, and imaging, are similarly dedicated and highly skilled. All have special expertise in treating patients with lung cancer and other thoracic malignancies.
Our scientists have the same commitment to eradicating lung cancer as I do. Our lab researchers work tirelessly seeking to discover new therapies and cures. Our clinical investigators are committed to opening new clinical trials that allow patients to access the latest treatments, in addition to standard therapy.
Thank you for visiting our site.
Sincerely,
David M. Jablons, M.D.
Professor of Surgery
Chief, Section of General Thoracic Surgery
Ada Distinguished Professor and Program Leader of Thoracic Oncology
University of California, San Francisco